Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Wyeth Launches Prevnar Vaccine Targeting Pediatric Patients

This article was originally published in PharmAsia News

Executive Summary

Wyeth Japan launched Prevnar pneumococcal vaccine in Japan Feb. 24. The vaccine targets children from 2 months to nine years of age and contains extracts from seven of the most common types of streptococcus pneumoniae bacteria. According to Wyeth, the vaccine can prevent 80 percent of severe infections caused by the bacteria. (Click here for more - Japanese language) "Wyeth Launches Pneumococcal Vaccine Feb. 24, Targets Infants And Children" - Nikkei Sangyo News (2/24/2010)
Advertisement
Advertisement
UsernamePublicRestriction

Register

SC074132

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel